Egalet Corp (20)

Browse by Contract Category

Contracts

Agreement and Plan of Merger, dated as of March 16, 2020, by and among Zyla Life Sciences, Alligator Zebra Holdings, Inc., Assertio Therapeutics, Inc., Zebra Merger Sub, Inc. and... (Filed With SEC on May 20, 2020)
Amended and Restated 2019 Stock-Based Incentive Compensation Plan, as amended (Filed With SEC on March 26, 2020)
Second Amended and Restated Nano-Reformulated Compound License Agreement dated January 27, 2020 among iCeutica Inc., iCeutica Pty Ltd., and Zyla Life Sciences US Inc (Filed With SEC on March 26, 2020)
Description of Securities (Filed With SEC on March 26, 2020)
Manufacturing and Supply Agreement by and between Zyla Life Sciences US Inc. and Jubilant HollisterStier LLC July 30, 2019 (Filed With SEC on November 14, 2019)
Amendment No. 3 to Asset Purchase Agreement, dated as of May 31, 2019 (Filed With SEC on June 6, 2019)
Separation Agreement dated as of December 31, 2019 between H. Jeffrey Wilkins and the Company (Filed With SEC on March 26, 2020)
Agreement and Plan of Merger, dated as of March 16, by and among Zyla Life Sciences, Alligator Zebra Holdings, Inc., Assertio Therapeutics, Inc., Zebra Merger Sub, Inc. and... (Filed With SEC on March 17, 2020)
Employment Agreement dated as of June 3, 2019 between H. Jeffrey Wilkins and the Company (Filed With SEC on November 14, 2019)
Separation Agreement, dated as of October 30, 2019, between Robert Radie and Zyla Life Sciences (Filed With SEC on October 30, 2019)
Employment Agreement, dated as of October 30, 2019, between Todd Smith and Zyla Life Sciences (Filed With SEC on October 30, 2019)
Retention Bonus Agreement, dated August 26, 2019 between the Company and Mark Strobeck (Filed With SEC on August 30, 2019)
Separation Agreement and General Release dated July 9, 2019 between Egalet Corporation (now Zyla Life Sciences) and Patrick M. Shea (Filed With SEC on August 13, 2019)
Separation Agreement and General Release dated May 28, 2019 between Egalet Corporation and Barbara Carlin (Filed With SEC on August 13, 2019)
Collaborative License, Exclusive Manufacture and Global Supply Agreement between G&W Laboratories, Inc. and Iroko Pharmaceuticals, LLC, as amended by Amendment 1 and Amendment 2... (Filed With SEC on May 17, 2019)
Amended and Restated Nano-Reformulated Compound License Agreement dated October 30, 2018 among iCeutica Inc., Iroko Pharmaceuticals, LLC and Iroko Properties Inc. (the Company... (Filed With SEC on May 17, 2019)
Egalet Corporation Form of Non-Qualified Stock Option Agreement (Filed With SEC on May 17, 2019)
Master Services Agreement made as of August 28, 2013 between Patheon Pharmaceuticals Inc. and Iroko Pharmaceuticals, LLC, as amended by an amendment thereto (the Company succeeded... (Filed With SEC on May 17, 2019)
Commercial Supply Agreement, effective October 1, 2018, between Iroko Pharmaceuticals, LLC and Catalent CTS, LLC (the Company succeeded Iroko as a party to this agreement) (Filed With SEC on May 17, 2019)
Form of Certificate of Common Stock (Filed With SEC on March 29, 2019)